Product search
Filter
Search results
Aprotinin
Aprotinin can be used in any application where inhibition of its targeted proteases is needed. Current uses include protein isolation, removal of reactive proteases through solid phase, inhibition of undesired proteolytic activity in laboratory assays, or other techniques; for blocking fibrinolytic activity in vitro; etc.
CoaChrom™ Moderate Abnormal Control Plasma
Moderate Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
CoaChrom™ Severe Abnormal Control Plasma
Severe Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
Bivalirudin (Angiox®) Plasma Calibrator
Calibrating the assays of bivalirudin using anti-IIa methods, especially with HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) or BIOPHEN DTI (ref. 220202).
Bivalirudin (Angiox®) Plasma Control
Quality control of clotting assays proposed for measuring bivalirudin concentrations in plasma (especially ref. CK002K, CK002L and 220202).
Fibrinogen, porcine
Fibrinogen, porcine, purified
BIOPHEN Factor IX (1)
Assay proposed for the measurement of factor IX activity in research applications.
Donor Plasma with Vitamin K antagonists (Warfarin-Sodium, Coumadin)
For all in vitro analyses that require vitamin K antagonist plasma.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.